Skip to main content
Journal cover image

Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures.

Publication ,  Journal Article
Farber, SH; Hatef, J; Han, JL; Marky, AH; Xie, J; Huang, K; Verla, T; Lokhnygina, Y; Collins, TA; Lad, SP
Published in: Neuromodulation
April 2016

OBJECTIVES: Chronic daily headache is a considerable source of morbidity for patients and also carries an enormous economic burden. Patients who fail standard medication regimens lack well-defined therapies, and neurostimulation is an emerging option for these patients. The purpose of this study was to analyze the cost utility of implantable neurostimulation for treatment of headache. METHODS: We utilized the Thompson Reuters Marketscan Data base to identify individuals diagnosed with headache disorders who underwent percutaneous neurostimulation. Healthcare expenditures for individuals who subsequently received permanent, surgically implanted neurostimulatory devices were compared to those who did not. Only individuals who sought implantable neurostimulation were included to account for headache severity. The cohorts were adjusted for comorbidity and prior headache-related expenses. Costs were modeled longitudinally using a generalized estimating equation. RESULTS: A total of 579 patients who underwent percutaneous trial of neurostimulation were included, of which 324 (55.96%) converted to permanent neurostimulation within one year. Unadjusted expenditures were greater for patients who underwent conversion to the permanent neurostimulation device, as expected. Costs grew at a lower rate for patients who converted to permanent device implantation. Cost neutrality for patients receiving the permanent device was reached in less than five years after the enrollment date. The mean cost of conversion to a permanent implantation was $18,607.53 (SD $26,441.34). CONCLUSIONS: Our study suggests that implantable neurostimulation reduces healthcare expenditures within a relatively short time period in patients with severe refractory headache.

Duke Scholars

Published In

Neuromodulation

DOI

EISSN

1525-1403

Publication Date

April 2016

Volume

19

Issue

3

Start / End Page

319 / 328

Location

United States

Related Subject Headings

  • Young Adult
  • Skin
  • Regression Analysis
  • Patient Acceptance of Health Care
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Implantable Neurostimulators
  • Humans
  • Health Expenditures
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Farber, S. H., Hatef, J., Han, J. L., Marky, A. H., Xie, J., Huang, K., … Lad, S. P. (2016). Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures. Neuromodulation, 19(3), 319–328. https://doi.org/10.1111/ner.12393
Farber, S Harrison, Jeffrey Hatef, Jing L. Han, Andrew H. Marky, Jichun Xie, Kevin Huang, Terence Verla, Yuliya Lokhnygina, Timothy A. Collins, and Shivanand P. Lad. “Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures.Neuromodulation 19, no. 3 (April 2016): 319–28. https://doi.org/10.1111/ner.12393.
Farber SH, Hatef J, Han JL, Marky AH, Xie J, Huang K, et al. Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures. Neuromodulation. 2016 Apr;19(3):319–28.
Farber, S. Harrison, et al. “Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures.Neuromodulation, vol. 19, no. 3, Apr. 2016, pp. 319–28. Pubmed, doi:10.1111/ner.12393.
Farber SH, Hatef J, Han JL, Marky AH, Xie J, Huang K, Verla T, Lokhnygina Y, Collins TA, Lad SP. Implantable Neurostimulation for Headache Disorders: Effect on Healthcare Utilization and Expenditures. Neuromodulation. 2016 Apr;19(3):319–328.
Journal cover image

Published In

Neuromodulation

DOI

EISSN

1525-1403

Publication Date

April 2016

Volume

19

Issue

3

Start / End Page

319 / 328

Location

United States

Related Subject Headings

  • Young Adult
  • Skin
  • Regression Analysis
  • Patient Acceptance of Health Care
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
  • Implantable Neurostimulators
  • Humans
  • Health Expenditures